Notably, our results also indicate that PROX1, a transcription factor previously implicated in RMS growth (Gizaw et al, 2022), functions as an upstream regulator of cholesterol biosynthesis, further anchoring this metabolic pathway in the broader transcriptional network that sustains tumor survival. The gene discussed is PROX1; the disease is neoplasm.